Dr Reddy’s

Why 2018 will be a challenging year for pharmaceuticals

New Delhi, March 29, 2018: Management teams were generally optimistic on the outlook for domestic Indian markets, with sales growth…

7 years ago

Dr Reddy’s gets EIR from USFDA for Srikakulam plant – The Monetary Circumstances

New Delhi, February 27, 2018: Pharma major Dr Reddy’s today said it has gotten the foundation investigation report (EIR) from…

7 years ago

US FDA cautioning letters to Indian pharma decrease

New Delhi, February 24, 2018: Indian pharmaceutical organizations have gotten 29 for every penny of US FDA cautioning letters in…

7 years ago

Warren Smorgasbord’s Teva venture – a nostalgic sponsor or restoration in pharma segment anticipated?

New Delhi, February 16, 2018: Will the Indian speculators take after Warren Smorgasbord by putting resources into the pharma organizations?…

7 years ago

Dr Reddy’s launches Tetrabenazine Tablets in US market

Mumbai, February 03, 2018: Pharma Major, Dr.Reddy’s Laboratories has launched Tetrabenazine Tablets, a therapeutic equivalent generic version of Xenazine (tetrabenazine)…

7 years ago